UPDATE 1-Valeant rejected joint takeover bid from Takeda, TPG in spring-WSJ

May 26 (Reuters) - Valeant Pharmaceuticals International Inc

received a joint takeover offer from Japan's Takeda

Pharmaceutical Co Ltd and TPG Capital Management LP

this spring that the Canadian drugmaker rejected, the

Wall Street Journal reported, citing people familiar with the

matter.

Read more